Evidence map›Paper›PMID 25919188›Full record

ArticleEndocrinology2015

Developmental Programming: Prenatal and Postnatal Androgen Antagonist and Insulin Sensitizer Interventions Prevent Advancement of Puberty and Improve LH Surge Dynamics in Prenatal Testosterone-Treated Sheep.

Vasantha Padmanabhan, Almudena Veiga-Lopez, Carol Herkimer, Bachir Abi Salloum, Jacob Moeller, Evan Beckett, Rohit Sreedharan

Open access · bronzeAbstract read
In one paragraph

Article in Endocrinology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
7.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 52 citations in OpenAlex.

  1. Testosterone mediates life-history trade-offs in female mammals.Biological reviews of the Cambridge Philosophical Society · 2025
    Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Androgen-induced epigenetic modulations in the ovary.The Journal of endocrinology · 2021
    Review
  8. Article
  9. Article
  10. Article
  11. [Research progress on the role of pentraxin 3 in polycystic ovary syndrome].Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences · 2020
    Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. The Mechanism of Androgen Actions in PCOS Etiology.Medical sciences (Basel, Switzerland) · 2019
    Review
  19. Developmental Programming of PCOS Traits: Insights from the Sheep.Medical sciences (Basel, Switzerland) · 2019
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Vasantha PadmanabhanDepartment of Pediatrics, University of Michigan, Ann Arbor, Michigan 48105.
Almudena Veiga-LopezDepartment of Pediatrics, University of Michigan, Ann Arbor, Michigan 48105.
Carol HerkimerDepartment of Pediatrics, University of Michigan, Ann Arbor, Michigan 48105.
Bachir Abi SalloumDepartment of Pediatrics, University of Michigan, Ann Arbor, Michigan 48105.
Jacob MoellerDepartment of Pediatrics, University of Michigan, Ann Arbor, Michigan 48105.
Evan BeckettDepartment of Pediatrics, University of Michigan, Ann Arbor, Michigan 48105.
Rohit SreedharanDepartment of Pediatrics, University of Michigan, Ann Arbor, Michigan 48105.
University of Michigan–Ann Arbor · US

Funding

Regional Pilot And Feasibility Study Grants ProgramP30DK020572 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Mehboob A Hussain · 2013 to 2026
$24.3M
STEROIDAL AND METABOLIC MEDIATION OF NEUROENDOCRINE CIRCUITRYP01HD044232 · NICHD · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI PADMANABHAN, VASANTHA · 2004 to 2015
$12.9M
Postdoc Stipend Supplement: Developmental Origins of Metabolic Disorders T32T32DK071212 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI DAVID P OLSON, Kanakadurga Singer · 2005 to 2026
$5.4M
NICHD NIH HHS P01 HD044232NICHD NIH HHS P01 HD44232NIDDK NIH HHS P30 DK020572NIDDK NIH HHS T32 DK071212
6 · The paper itself

Abstract

Prenatal T excess induces maternal hyperinsulinemia, early puberty, and reproductive/metabolic defects in the female similar to those seen in women with polycystic ovary syndrome. This study addressed the organizational/activational role of androgens and insulin in programming pubertal advancement and periovulatory LH surge defects. Treatment groups included the following: 1) control; 2) prenatal T; 3) prenatal T plus prenatal androgen antagonist, flutamide; 4) prenatal T plus prenatal insulin sensitizer, rosiglitazone; 5) prenatal T and postnatal flutamide; 6) prenatal T and postnatal rosiglitazone; and 7) prenatal T and postnatal metformin. Prenatal treatments spanned 30-90 days of gestation and postnatal treatments began at approximately 8 weeks of age and continued throughout. Blood samples were taken twice weekly, beginning at approximately 12 weeks of age to time puberty. Two-hour samples after the synchronization with prostaglandin F2α were taken for 120 hours to characterize LH surge dynamics at 7 and 19 months of age. Prenatal T females entered puberty earlier than controls, and all interventions prevented this advancement. Prenatal T reduced the percentage of animals having LH surge, and females that presented LH surge exhibited delayed timing and dampened amplitude of the LH surge. Prenatal androgen antagonist, but not other interventions, restored LH surges without normalizing the timing of the surge. Normalization of pubertal timing with prenatal/postnatal androgen antagonist and insulin sensitizer interventions suggests that pubertal advancement is programmed by androgenic actions of T involving insulin as a mediary. Restoration of LH surges by cotreatment with androgen antagonist supports androgenic programming at the organizational level.

Indexed as

Androgen AntagonistsAndrogensAnimalsEstrous CycleFemaleFetal DevelopmentFlutamideHypoglycemic AgentsLuteinizing HormoneMetforminPolycystic Ovary SyndromePregnancyPrenatal Exposure Delayed EffectsRosiglitazoneSexual MaturationSheepAndrogen AntagonistsAndrogensFlutamideHypoglycemic AgentsLuteinizing HormoneMetforminRosiglitazoneTestosteroneThiazolidinediones

Identifiers

PMID25919188
PMCPMC4475717
OpenAlexW2055206546

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.